Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis Courtney E. McAleeseNeville J. ButcherRodney F. Minchin Preclinical study Open access 02 August 2022 Pages: 223 - 236
Clever-1 positive macrophages in breast cancer Minna MutkaReetta VirtakoivuPäivi Heikkilä Preclinical study Open access 02 August 2022 Pages: 237 - 248
The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary Jan J. JobsenHenk StruikmansHarald J. Heijmans Preclinical study 08 August 2022 Pages: 249 - 262
BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance Midas M. KuilmanArchitha EllappalayamAnnuska M. Glas Preclinical study Open access 19 August 2022 Pages: 263 - 274
An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer Elgene LimFrances BoyleMeritxell Bellet Ezquerra Clinical trial Open access 01 August 2022 Pages: 275 - 287
Surgical and obstetric outcomes of breast cancer surgery during pregnancy: a nationwide database study in Japan Takaaki KonishiMichimasa FujiogiHideo Yasunaga Clinical trial 02 August 2022 Pages: 289 - 299
Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study Xinguang WangZhaoqing FanTao Ouyang Clinical trial 02 August 2022 Pages: 301 - 310
Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study Mitsuo TeradaNaoto KondoTatsuya Toyama Clinical trial 08 August 2022 Pages: 311 - 323
The influence of body mass index on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in women with early-stage breast cancer Lishi LinMarcel SoesanAlwin D. R. Huitema Clinical trial Open access 16 August 2022 Pages: 325 - 331
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital Niamh CunninghamScott ShepherdAlicia F. C. Okines Clinical trial 17 August 2022 Pages: 333 - 340
Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study Elaine M. WalshAyca GucalpTiffany A. Traina Clinical trial 20 August 2022 Pages: 341 - 351
Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women's Health History Study Ugonna IhenachoAnn S. HamiltonEllen M. Velie Epidemiology 04 August 2022 Pages: 353 - 366
Correlation of tumour subtype with long-term outcome in small breast carcinomas: a Swedish population-based retrospective cohort study Gunilla RaskAnoosheh NazemroayaMalin Sund Epidemiology Open access 06 August 2022 Pages: 367 - 377
Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study Kristina EngvallHenrik GréenElisabeth Åvall-Lundqvist Epidemiology Open access 09 August 2022 Pages: 379 - 391
A mixed-methods study of the technical feasibility and patient acceptability of a real-time adherence monitor in breast cancer survivors taking adjuvant endocrine therapy Emma E. BrightSarah R. GenungJoanna J. Arch Epidemiology 12 August 2022 Pages: 393 - 399
Cardiotoxicity among socioeconomically marginalized breast cancer patients Yan LuAaron W. GehrRohit P. Ojha Epidemiology Open access 15 August 2022 Pages: 401 - 411
Barriers to breast reconstruction for socioeconomically disadvantaged women Trista J. StankowskiJessica R. SchumacherHeather B. Neuman Epidemiology 15 August 2022 Pages: 413 - 419
Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes Soumya G. ChikermaneManvi SharmaMichael L. Johnson Epidemiology 15 August 2022 Pages: 421 - 430
Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype Fan ZangXinyun DingYuntao Xie Epidemiology 16 August 2022 Pages: 431 - 439
Treatment of HR+/HER2− breast cancer in urban mainland China: results from the CancerMPact Survey 2019 Bhavna MuraliLaura DurbinOtávio Clark Epidemiology Open access 20 August 2022 Pages: 441 - 451
Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine Anastasiia SamusievaSvitlana SergaIryna Kozeretska Brief Communication 05 August 2022 Pages: 453 - 459
Letter to the editor regarding “Hsp90 inhibitor-loaded IR780 micelles for mitochondria-targeted mild-temperature photothermal therapy in xenograft models of human breast cancer” Jianquan YangWen GuoMan Lu Letter to the Editor 05 August 2022 Pages: 461 - 462